Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00748254

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Status
Recruiting
Phase
Study type
Observational
Enrollment
113 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Detailed description

The objective of this proposal is to adapt photoacoustic tomography (PAT), a novel, nonionizing, noninvasive, laser-based technology, for structural and functional imaging of human peripheral joints affected by inflammatory arthritis. Combining the advantages of both light and ultrasound scanning, PAT holds promise to present objective optical information in subsurface joint tissues with high sensitivity and high spatial resolution. This could be of considerable help in the early detection of inflammatory joint diseases. PAT may also prove useful in further understanding the pathophysiology of these disorders and assisting with therapeutic decisions, including assessment of new pharmacological therapies. In January 2026, the decision was made to reopen recruitment for this study to collect additional data to support future clinical trial work and funding.

Conditions

Interventions

TypeNameDescription
PROCEDURELaser Based Photoacoustic Tomography, MRI, UltrasoundHealthy subjects will have scans on finger joints with any of the scanning methods described above.
PROCEDURElaser based photoacoustic tomography, MRI, ultrasoundSubjects with arthritis will have scans on finger joints with any of the scanning methods described above.

Timeline

Start date
2011-12-01
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2008-09-08
Last updated
2026-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00748254. Inclusion in this directory is not an endorsement.